Medications like Ozempic ‘transformed’ diabetes care because they improved health outcomes, say expertsObesity rates have decreased slightly in the US and while it’s too early to say whether the trend will hold and what’s causing the change, experts believe weight-loss drugs could be playing a role in continuing to lower obesity and reduce related health risks.These medications – Ozempic, Wegovy, Mounjaro and others – are called GLP-1 agonists, and they were originally developed to treat type 2 diabetes. But they also show great promise for treating obesity and other health conditions, like heart disease, kidney and liver issues, sleep apnea, asthma, Covid complications and cancer, among others. Continue reading…
Source link : https://www.theguardian.com/us-news/2024/oct/18/weight-loss-drugs-ozempic-obesity
Author : Melody Schreiber
Publish date : 2024-10-18 14:00:50
Copyright for syndicated content belongs to the linked Source.
Weight-loss drugs could be key in lowering US obesity rates – experts
